Quantifying Pill Disutility Associated With Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment
Circulation: Cardiovascular Quality and Outcomes · 2024-11 · 17 (11)
DOI: 10.1161/circoutcomes.124.011069 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2024-11. Verfasst von Alexander Chaitoff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA (A.C., J.C.…. Hauptthemen laut MEDLINE: Medication Adherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Quantifying patient-reported pill disutility is important for understanding the risk-benefit tradeoffs of taking medications. The objective of this study was to quantify and compare the pill disutility associated with starting a new medication and continuing an existing medication for cardiometabolic disease prevention in a sample of older adults in the United States. METHODS: We enrolled adults aged ≥60 years from an online panel. Respondents completed a survey that included a 2-armed experiment that randomized them to either a starting or a continuing scenario in which they were instructed that their doctor recommended they start or continue, respectively, a daily medication that prevents heart attacks and strokes. Pill disutility was calculated using a time-tradeoff method with time willing to trade obtained via alternating dichotomous choice contingent valuation design. Pill disutility was described within each scenario overall and by subgroups and then compared across scenarios using the Kruskal-Wallis test and multivariable fractional logistic regression. RESULTS: A total of 621 respondents with a mean age of 69 years were included in the final analysis. A majority were taking medications (n=84.5%, n=525) and had at least 1 chronic cardiometabolic disease (78.7%, n=489). Pill disutility associated with starting a new medication was 0.0662 (SD, 0.13), while pill disutility associated with continuing an existing medication was 0.0378 (SD, 0.10; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA (A.C., J.C.L., N.H., K.T.J., N.K.C.).
- Institute of Primary Health Care, University of Bern, Switzerland (K.T.J.).
ORCID-Profile: Alexander Chaitoff, Julie C Lauffenburger, Nancy Haff, Katharina Tabea Jungo, Niteesh K Choudhry
Zitieren
APA
Chaitoff, A., Lauffenburger, J. C., Haff, N., Jungo, K. T., & Choudhry, N. K. (2024). Quantifying Pill Disutility Associated With Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment. Circulation: Cardiovascular Quality and Outcomes, 17(11). https://doi.org/10.1161/circoutcomes.124.011069
Vancouver
Chaitoff A, Lauffenburger JC, Haff N, Jungo KT, Choudhry NK. Quantifying Pill Disutility Associated With Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment. Circulation: Cardiovascular Quality and Outcomes. 2024;17(11). doi:10.1161/circoutcomes.124.011069
BibTeX
@article{Chaitoff2024,
author = {Chaitoff, Alexander and Lauffenburger, Julie C and Haff, Nancy and Jungo, Katharina Tabea and Choudhry, Niteesh K},
title = {Quantifying Pill Disutility Associated With Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2024},
volume = {17},
number = {11},
doi = {10.1161/circoutcomes.124.011069}
}
EUVIMED